Altasciences is pleased to announce the opening of Algorithme Pharma USA, further expanding the Company’s North American footprint and ability to provide comprehensive Bioequivalence and Phase I/IIa clinical drug development capabilities in the United States.
During a recent drug development symposium held at the NEOMED Institute in Montreal, Dr. Marc Lefebvre, Vice-President Scientific & Regulatory Affairs, Algorithme Pharma Inc., addressed life science executives on developing efficient First-In-Human (FIH) clinical trials to help reduce costs and shorten the timeline for approval of new drugs.
Algorithme Pharma, a full service early stage clinical research organization, has been presented with the Innovation, Productivity, Quality and Regulatory CRO leadership awards by Life Science Leader Magazine.
Algorithme Pharma, a leading early stage clinical research organization, is pleased to announce the expansion of its clinical facility located in Montreal, Quebec, with the addition of a 7th clinical unit for a total 265 beds.
Algorithme Pharma, a leading early stage clinical research organization, is pleased to offer sponsors increased patient access in key therapeutic areas through the strategic partnership with Hôpital Maisonneuve-Rosemont (HMR).